Angion Biomedica Corp. (40) | Uncategorized (7)

Recent Contracts

Amendment First Amendment dated July 1, 2021 to Licensing Agreement, dated November 6, 2020, by and between Angion Biomedica Corp. and Vifor (International) Ltd (Filed With SEC on March 30, 2022)
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 30, 2022)
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 30, 2021)
Licensing Agreement, dated August 22, 2018, by and between Angion Biomedica Corp. and Sinovant Sciences HK Limited (Filed With SEC on January 15, 2021)
Subcontractor Agreement, dated November 15, 2019, by and between Angion Biomedica Corp. and The Regents of the University of Michigan (Filed With SEC on January 15, 2021)
Licensing Agreement, dated November 6, 2020, by and between Angion Biomedica Corp. and Vifor (International) Ltd (Filed With SEC on January 15, 2021)
Offer Letter, dated November 27, 2019, as amended, by and between Angion Biomedica Corp. and Jennifer J. Rhodes (Filed With SEC on January 15, 2021)